… growth factor receptor (EGFR), a member of the human epidermal growth factor receptor (HER)–erbB
family of receptor … processes involved in tumor growth and progression, including …

… Inhibition of the epidermal growth factor receptor (EGFR) is a fastly developing field in
preclinical and clinical cancer research. This review presents the current status of knowledge and …

… relation between hormone receptor expression and growth factor receptor expression and
… of breast carcinomas and linked them to varying clinical outcomes.42, 43 Basal-type breast …

… growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid
tumors that express the epidermal growth factor receptor. J Clin Oncol 2004; 22:175-184. 28. …

… The impact of epidermal growth factor receptor (EGFR) and KRAS mutations on clinical
outcomes … We have created a database of five clinical trials from the United States and Europe, in …

Purpose Overexpression of epidermal growth factor receptor (EGFR) is common in head and
neck squamous cell carcinoma (HNSCC). Recent studies showed that EGFR inhibitors are …

… cancer (mCRC) to anti–epidermal growth factor receptor (EGFR) monoclonal antibodies
has a … role of EGFR GCN, in terms of clinical outcome, in patients treated with panitumumab. …

… The−216G/T, −191C/A, intron 1 and Arg497Lys epidermal growth factor receptor (EGFR) …
EGFR intron 1 and –216G/T polymorphisms influence clinical outcomes in gefitinib-treated …

… of the epidermal growth factor receptor (EGFR) in osteosarcomas has repeatedly been
described. With the introduction of anti-EGFR–targeted therapies in clinical practice, these …

… the prognostic implications of insulin-like growth factor-1 receptor (IGF-1R), epidermal
growth factor receptor (EGFR) and human epidermal growth factor receptor (HER)-2 in patients …